Entwicklung von niedermolekularen Verbindungen zur Blockierung des CD93 Signalwegs bei Leukämiepatienten

Beschreibung

The aim of the current InnoSuisse application is to optimize small molecules, which were identified in a drug library screen to block CD93-signaling in LSCs and showed a positive clinical response, in order to develop lead candidates with a novel chemical scaffold and own IP to treat leukemia.